Skip to main content
SpringerLink
Log in

Systemische und lokale Corticosteroid-Therapie — aus rheumatologischer Sicht

  • Conference paper
Dermatologie und Rheuma

  • 17 Accesses

Zusammenfassung

Die Corticosteroid-Therapie greift in alle wesentlichen Pathomechanismen der entzündlich-rheumatischen Immunopathien ein und hat daher bei allerdings strenger Differentialindikation und -kontraindikation einen hohen Stellenwert bei der medikamentösen Behandlung der systemischen Kollagenosen, der systemischen chronischen Oligo- und Polyarthritiden sowie der systemischen Polymyalgia rheumatica (Polymyalgia arteriitica).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Blackwell GL, Carnuccio R, Di Rosa M et al (1980) Macrocortin: A polypeptide causing the antiphospholipase effect of glucocorticoids. Nature (London) 147, 287

    Google Scholar 

  2. Hirata F, Schiffmann E, Neukatasubramanian K et al (1980) A phospholipase A2 inhibitory protein in rabbit neutrophils induced by glucocorticoids. Proc Natl Acad Sci USA 55, 2533

    Article  Google Scholar 

  3. Jones CJP, Morris KJ and Jayson MIV (1983) Prednisolone inhibts phagocytosis by polymorphonuclear phagocytes via steroid receptor mediated events. Ann Rheum Dis 42, 56–62

    Article  PubMed  CAS  Google Scholar 

  4. Bult H and Herman AG (1985) Vascular responses and their suppression: The role of endothelium. In: Handbook of Pharmacology of Inflammation. JL Bonta, MA Bray MJ Parnham ed. Elsevier Science Publishers

    Google Scholar 

  5. Crabtree GR, Gillis S, Smith KA and Munck A (1979) Glucocorticoids and immune response. Arthritis Rheum, 22, 11, 1246

    Article  PubMed  CAS  Google Scholar 

  6. Gowen M, Elford PR, Skjodt et al (1985) Tissue destruction and its prevention. In: Handbook of Inflammation Vol 5: The pharmacology of Inflammation. JL Bonta, Bray MA, MJ Parnham ed. Elsevier Science Publishers

    Google Scholar 

  7. Hermanns Ph, Verbruggen G, Veys EM et al (1982) Influence of low dose corticosteroid administration on the lymphocytes subpopulations. J Rheumatology, 9, 4, 648

    CAS  Google Scholar 

  8. Bertouch JV, Roberts-Thomson, Smith MD et al (1986) Methylprednisolone infusion therapy in rheumatoid arthritis patients. Arthritis Rheum, 29, 32–38

    Article  PubMed  CAS  Google Scholar 

  9. Dreher R: Unpublished data

    Google Scholar 

  10. Fauci AS, Dale DC (1974) The effect of in vivo hydrocortisone on subpopulations of human lymphocytes. J Clin Invest, 53, 240–246

    Article  PubMed  CAS  Google Scholar 

  11. Fauci AS, Dale DC (1975) Alternate day prednisolone therapy and human lymphocyte subpopulations: Effect of corticosteroids. J Clin Invest, 55, 22–32

    Article  PubMed  CAS  Google Scholar 

  12. Yu DTY, Clemens PJ, Paulus HE et al (1974) Human lymphocyte subpopulations: Effect of corticosteroids. J Clin Invest, 53, 565–571

    Article  PubMed  CAS  Google Scholar 

  13. Haynes BF, Fauci AS (1978) The differential effect of in vivo hydrocortisone on the kinetics of subpopulations of human peripheral blood thymus-derived lymphocytes. J Clin Invest, 61, 703–707

    Article  PubMed  CAS  Google Scholar 

  14. Stevenson HC, Fauci AS (1981) Effects of corticosteroids on the function and distribution human lymphocytes. In: Franklin ED ed. Clinical Immunology Update, New York Elsevier North Holland Inc, 337–350

    Google Scholar 

  15. Brandhurt J, Peters ND, Ejstrup L et al (1963) Steroids and complement activation in rheumatoid arthritis. Lancet, 346–347

    Google Scholar 

  16. Dreher R (1983) Experimentelle Immunarthritis und ihre Bedeutung in der Rheumatherapieforschung und Rheumapathologie. Werk-Verlag Dr. Edmund Banaschewski München-Gräfelfing

    Google Scholar 

  17. Butler WT, Rossen RD (1973) Effects of corticosteroids in immunity in man I: Decreased serum IgG concentrations caused by 3 or 5 days of high dosis of methylprednisolone. J Clin Invest, 52, 2629–2640

    Article  PubMed  CAS  Google Scholar 

  18. Fehr K, Velvart M, Roos K (1986) Intraartikuläre Applikation von kortikoidhaltigen Liposomen am gesunden und arthritischen Kniegelenk von Kaninchen. EULAR Bulletin, 2, 44–50

    Google Scholar 

  19. Link P und Dreher R (unveröffentlicht) Intraartikuläre Dexamethason-Liposomen-Therapie bei aktivierter Arthrose.

    Google Scholar 

  20. Annefeld M: Der Chondrocyt, das lebende Element des Gelenkknorpels. In: Gelenkknorpel und Arthrose. Faßbender HG, Annefeld M, Wilhelmi G, Maier, R. Documenta Geigy

    Google Scholar 

  21. Annefeld M: In: Der internistisch-orthopädische Rheumapatient. Vortragsreihe „Medica 1986“Düsseldorf

    Google Scholar 

  22. Konutz S, Cohn R (1969) Initial treatment of renal allograft with large intrarenal drugs of immunosuppressive drugs. Lancet, 1, 338–340

    Article  Google Scholar 

  23. Bell P, Caiman K, Wood R et al (1971) Reversal of acute clinical and experimental organ rejection using large dosis of intravenous prednisolone. Lancet, 1, 876–880

    Article  PubMed  CAS  Google Scholar 

  24. Turcotte J, Feduska N, Carpenter E et al (1972) Rejection crisis in human renal transplant recipients. Arch Surg, 105, 230–236

    PubMed  CAS  Google Scholar 

  25. Orta-Sibu N, Chantier C, Benick M, Heycock G (1982) Comparison of high dose intravenous methylprednisolone with low dose oral prednisolone in acute renal allograft rejection in children. Br Med J, 285, 258–260

    Article  CAS  Google Scholar 

  26. Fauci AS, Dale DC, Bolow JE (1976) Glucocorticoidtherapy: Mechanism of action and clinical considerations. Ann Intern Med, 84, 304–315

    PubMed  CAS  Google Scholar 

  27. Cathcart ES, Idleson BA, Schreinberg MA, Conser WG (1976) Beneficial effect of methylprednisolone “pulse”-therapy in diffuse proliferative lupus nephritis. Lancet, 1, 163–166

    Article  PubMed  CAS  Google Scholar 

  28. Kimberly R, Lockshin M, Sherman R et al (1979) Clinical efficacy of high dose intravenous methylprednisolone pulse therapy of SLE. Arthritis Rheum, 22, 629

    Google Scholar 

  29. Eyanson S, Passo MH, Aldobenson MA et al (1980) Methylprednisolone pulse therapy for nonrenal lupus erythematosus. Ann rheum Dis, 39, 377

    Article  PubMed  CAS  Google Scholar 

  30. Oto A, Sozen T, Boyacioglu et al (1981) Life threatening non-renal SLE. Ann rheum Dis, 40, 630

    Article  PubMed  CAS  Google Scholar 

  31. Kimberly RP (1982) Pulse methylprednisolone in SLE. Clin rheum dis, 8, 261

    PubMed  CAS  Google Scholar 

  32. Isenberg DA, Morrow JW, Snaith MC (1982) Methylprednisolone pulse therapy in the treatment of systemic lupus erythematosus. Ann rheum Dis, 41, 347

    Article  PubMed  CAS  Google Scholar 

  33. Röckel A, Abdelhamid S, Bandilla K, Fiegel P und Walb C (1986) Hochdosierte Corticoidtherapie und Plasmapharese bei rasch progredienter Glomerulonephritis. Dtsch Ges Rheumatologie Freiburg

    Google Scholar 

  34. Neumann V, Hopkins R, Dixon J et al (1985) Combination therapy with pulsed methylprednisolone in rheumatoid arthritis. Ann rheum Dis, 44, 747–751

    Article  PubMed  CAS  Google Scholar 

  35. Fan PT, Yu DTY, Clements PJ, Fowlston S et al (1978) Effect of corticosteroids on the human immune response: Comparison of the one and three daily 1 g intravenous pulses of methylprednisolone. J Lab Clin Med, 91, 625–634

    PubMed  CAS  Google Scholar 

  36. Liebling MR, Leib E, McLaughlin K et al (1981) Pulse methylprednisolone in rheumatoid arthritis: A double blind crossover trial. Ann Int Med, 94, 21–26

    PubMed  CAS  Google Scholar 

  37. Empire Rheumatism Council (1957) Multicenter controlled trial comparing cortisone acetate and acethyl-salicylic acid in the long term treatment of rheumatoid arthritis: Results of three years treatment. Ann rheum Dis, 16, 277–289

    Article  Google Scholar 

  38. Barnett E, Nordin BEC (1960) The radiologic diagnosis of osteoporosis: A new approach. Clin Radiol 11, 166–174

    Article  PubMed  CAS  Google Scholar 

  39. Williams JA, Baylis M, English J (1981) High dose intravenous methylprednisolone (pulse therapy) in the treatment of rheumatoid disease. Scand J Rheumatology, 10, 153–155

    Article  CAS  Google Scholar 

  40. Williams IA, Baylis EM, Shipley ME (1982) A double blind placebo controlled trial of methylprednisolone pulse therapy in active rheumatoid disease. Lancet, 31, 237–239

    Article  Google Scholar 

  41. Menkes CJ, Brandley M, Carter H et al (1983) Polyarthrite rhumatoide. Traitment des poussées par assant cortisonique. La presse medicale, 12, 35, 2186

    PubMed  CAS  Google Scholar 

  42. Duquesnoy B, Dassonville P (1984) Utilisation d’assants cortisoniques («Pulse Methylprednisolone») dans la polyarthritide rheumatoide, resultats preliminaires. Larc Medical, 4, 254–256

    PubMed  CAS  Google Scholar 

  43. Duquesnoy B, Vannimenus PY, Thevenon A and Delcambe B (1984) Utilisation d’une corticotherapie massive intraveneuse («Methylprednisolone pulse») dans la polyarthritite rheumatoide. Revue du Rhumatisme, 51, 477–481

    CAS  Google Scholar 

  44. Garrott R, Paulus H (1980) Complication of intravenous methylprednisolone pulse therapy. Arthritis Rheum, 23, 677

    Google Scholar 

  45. Hess EV, Pamela L and Kammen L (1981) Pulse therapy in rheumatoid arthritis, editorial notes. Ann Int Med, 94, 128–129

    PubMed  CAS  Google Scholar 

  46. Wollheim FA (1984) Acute and long term complications of corticosteroid pulse therapy. Scand J Rheumatology Suppl 54, 27–32

    Article  CAS  Google Scholar 

  47. Arlet J (1984) La corticotherapie en «bolus» en rhumatologie. La Presse Medicale, 13, 20, 1269–1271

    PubMed  CAS  Google Scholar 

  48. Barry N (1985) The use of high-dose Pulse methylprednisolone in rheumatoid arthritis: unproved therapy. Arch Intern Med, 145, 8, 1483–1484

    Article  PubMed  CAS  Google Scholar 

  49. Zarro VJ (1986) Steroid Pulse Therapy. Clin Pharmakol, 33, 217–219

    CAS  Google Scholar 

  50. Jamieson TH (1986) Corticosteroids for rheumatic disease. 2. Effect on disease states, effect on bone. Postgrad Med, 79, 247–250

    PubMed  CAS  Google Scholar 

  51. Fechner C, Kaltenbach E, Dreher R (1985) Wirkungen und Nebenwirkungen der Prednisolon-Pulstherapie bei der Behandlung der aktiven chronischen Polyarthritis. 91. Tagung der Dtsch Ges Inn Med Wiesbaden

    Google Scholar 

  52. Dreher R (1986) Cortisontherpie: Erfahrungen mti hochdosierter Stoßtherapie. Int Symposium 22.–26.10.1986, Taormina

    Google Scholar 

  53. Stubbs SS, Morrell RM (1973) Intravenous methylprednisolone sodium succinate: Adverse reactions reported in association with immunsuppressive therapy. Transplant Proc, 9, 1145

    Google Scholar 

  54. McDouglas BA, Whittier FC, Cross DE (1976) Sudden death after bolus steroid therapy for acute rejection. Transplant Proc, 8, 493

    Google Scholar 

  55. Bocanegra TS, Casbaneda MD, Espinoza R et al (1981) Sudden death after methylprednisolone pulse therapy. Ann Intern Med, 95, 122

    PubMed  CAS  Google Scholar 

  56. Moses RE, McCormick A, Nickey W (1981) Fatal arrhythmia after pulse methylprednisolone therapy. Ann Intern Med, 95, 781

    PubMed  CAS  Google Scholar 

  57. Thompson JF, Chalmers DH, Wood RF et al (1983) Sudden death following high-dose intravenous methylprednisolone Transplantation, 36, 594–596

    CAS  Google Scholar 

  58. Mendelson LM, Meltner EO, Hamburger RN (1974) Anaphylaxis-like reactions to corticoid therapy. J Allergy Clin Immunol, 54, 125

    Article  PubMed  CAS  Google Scholar 

  59. Hayhurst M, Brande A, Benatar SR (1978) Anaphylactic-like reaction to hydrocortisone. S Afr Med J, 53, 259

    PubMed  CAS  Google Scholar 

  60. Freedman MD, Schocket AL, Chapal N, Gerbol JG (1981) Anaphylaxis after intravenous methylprednisolone administration. JAMA, 245, 607

    Article  PubMed  CAS  Google Scholar 

  61. Becq H and Dequeker J (1983) Hypersensitivity reaction to pulse dose of methylprednisolone (Solumedrol): A case report. Acta Clinica Belgica, 38, 262–264

    PubMed  CAS  Google Scholar 

  62. Ayoub WT, Torretti D, Harrington M (1983) Central nervous system manifestation after pulse therapy for systemic lupus erythematosus. Arthritis Rheum, 26, 809–810

    Article  PubMed  CAS  Google Scholar 

  63. Cathgart ES, Idleson BA, Scheinberg MA, Conser WG (1976) Beneficial effect of methylprednisolone pulse therapy in diffuse proliferative lupus nephritis. Lancet, 1, 163–166

    Article  Google Scholar 

  64. Isenberg DA, Morrow WJW, Snaith ML (1982) Methylprednisolone pulse therapy in the treatment of systemic lupus erythematosus. Ann Rheum Dis, 41, 347–351

    Article  PubMed  CAS  Google Scholar 

  65. Suchmann AL, Condemi JJ, Leddy JP (1983) Seizure after therapy with methylprednisolone (letter) Arthritis Rheum, 26, 117

    Google Scholar 

  66. Newmark KJ, Mitra S, Berman LB: Acute arthralgia following high-dose-intravenous methylprednisolone therapy. Lancet 174, 27, 229

    Google Scholar 

  67. Baily RR and Armour P (1974) Acute arthralgia after high-dose intravenous methylprednisolone. Lancet 26, 1024

    Google Scholar 

  68. Bennett WM and Strong D (1975) Arthralgia after high-dose steroids. Lancet 8, 332

    Article  Google Scholar 

  69. Lally E (1983) High dose corticosteroidtherapy: Association with non inflammatory synovial effusions. Arthritis Rheum, 26, 10, 1283–1287

    Article  PubMed  CAS  Google Scholar 

  70. Rickers M, Beding A, Christiansen C et al (1982) Corticoid induced osteopenia and vitamin-D metabolism. Effect of vitamin D2, calcium phosphate and sodium fluoride administration. Clin Endocrinol (Oxf), 16, 4, 409–415

    Article  CAS  Google Scholar 

  71. Caniggia A, Nuti R, Lore F et al (1981) Pathophysiology of the adverse effects of glucoactive corticosteroids on calcium metabolism in man. J Steroid Biochem, 15, 153–161

    Article  PubMed  CAS  Google Scholar 

  72. Fisher DE, Bickel WH, Holley KE (1969) Histologic demonstration of fat emboli in aseptic necrosis associated with hypercortisonism. Mayo Clin Proc, 44, 252–259

    PubMed  CAS  Google Scholar 

  73. Cruess RI (1977) Cortisone induced avascular necrosis of the femoral head. J Bone Joint Surg (Br) 59, 308–317

    CAS  Google Scholar 

  74. Silverman ED, Myones BL and Miller JJ (1984) Lymphocyte subpopulation alterations induced by intravenous megadose pulse methylprednisolone. J Rheumatology, 11, 3

    Google Scholar 

  75. Bertouch JV, Roberts-Thomson PJ, Smith MD et al (1986) Methylprednisolone infusion therapy in rheumatoid arthritis patients. Arthritis Rheum, 29, 32–38

    Article  PubMed  CAS  Google Scholar 

  76. Hermanns P, Verbruggen G, Veys E et al (1982) Influence of low dose corticosteroid administration on the lymphocytes subpopulation. J Rheumatol, 9, 648–649

    PubMed  CAS  Google Scholar 

  77. Schuyler MP, Gerblich A and Urda G (1984) Prednisone and T-cell subpopulation. Arch Intern Med, 973–975

    Google Scholar 

  78. Ten Berge RJM, Sauerwein HP, Jong SL and Schellekens PThA (1984) Administration of prednisolone in vivo affects the ratio of OKT 4/OKT 8 and the LDH-isoencyme pattern of human T-lymphocytes. Clin Immunol Immunpathol, 30, 91–103

    Article  Google Scholar 

Download references

Authors
  1. R. Dreher
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Zentrum der Dermatologie und Venerologie, Klinikum der Johann Wolfgang Goethe-Universität, Theodor-Stern-Kai 7, 6000, Frankfurt 70, Deutschland

    Hans Holzmann  & Wolfgang Christian Marsch  & 

  2. Dermatologische Klinik, Universitäts-Klinikum der Ruhr-Universität St. Josef-Hospital, Gudrunstraß56, 4630, Bochum, Deutschland

    Peter Altmeyer

  3. Hoechst AG Pharma Forschung, Postfach 800320, 6230, Frankfurt 80, Deutschland

    H. Gerhard Vogel

Rights and permissions

Reprints and permissions

Copyright information

© 1987 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Dreher, R. (1987). Systemische und lokale Corticosteroid-Therapie — aus rheumatologischer Sicht. In: Holzmann, H., Altmeyer, P., Marsch, W.C., Vogel, H.G. (eds) Dermatologie und Rheuma. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-72668-2_39

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-72668-2_39

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-72669-9

  • Online ISBN: 978-3-642-72668-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation